Modified Autologous MSC_apceth_101

N/A

Report date: 2025/05/14 18:13:58

Base Information

Drug NameModified Autologous MSC_apceth_101

Drug Alias NameAgenmestencel-T

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsGastrointestinal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesApceth Gmbh & Co Kg

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesApceth Gmbh & Co Kg

Active IndicationsN/A

Inactive IndicationsGastrointestinal Neoplasms

Other Information

ATC CodeN/A